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Abstract: Chemical prioritization has historically focused on indirect human exposure to chemicals, for example, 
through the environment, rather than on direct exposure during product use. Furthermore, exposure levels 
should be combined with toxicity data to more fully understand the risks of chemicals associated with consumer 
products. Hence, in order to prioritize substances used in consumer products, the entire continuum of usage 
and emissions, direct and environmental exposure, and toxic effects need to be taken into account. We present 
a case study on parabens which are used as preservatives in personal care products. We applied the concept of 
the product intake fraction, PiF (defined as the fraction of chemical taken by the population during product use 
and disposal) to calculate the exposure to parabens of the U.S. female population via cosmetic products such 
as shampoo, body lotion, and body wash. The PiF was found to vary between ~1-100% depending on product 
usage (for example, rinse-off versus leave-on). Exposure during product use was several orders of magnitude 
higher than exposure through the environment via disposal. Additionally, there can be considerable population 
variability in exposure factors, such as amount of product used, and uncertainty in factors such as chemical 
properties. Thus, we used Monte Carlo simulations to take into account population variability and uncertainty. 
The resulting modeled exposure distributions were within an order of magnitude of urine levels measured in the 
U.S. female population (NHANES). Furthermore, we used molecular docking models to identify target proteins 
with which parabens are likely to interact, with particular emphasis on proteins that regulate the endocrine 
system. Docking studies can be used in conjunction with high throughput toxicity datasets, such as ToxCast 
from the U.S. EPA, to further inform chemical toxicity. This toxicity information can then combined with the 
exposure model to identify priority chemicals. 
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Abstract: Triclosan (TCS) and triclocarban (TCC) are antimicrobial agents formulated in a wide variety of 
consumer products that are regulated by the U.S. Food and Drug Administration. According to available 
National Health and Nutrition Examination Survey (NHANES) data, exposure to TCS is prevalent in the general 
U.S. population. TCS has been detected previously in urine, blood, serum, plasma, human breast milk, and 
amniotic fluid. In 2014, the FDA is reviewing the use and effectiveness of these chemicals given their potential 
contribution to bacterial resistance to antibiotics, and endocrine disruption. TCS is known to interfere with thyroid 
hormone metabolism and has also been associated with allergy and weakening muscle contractibility. TCC has 
been shown to enhance androgen action and to elicit anti-inflammatory effects. Little is known about potential 
human effects of either compound in utero. In this study, we assessed prenatal exposure to TCS and TCC and 
associated birth outcomes including gestational age, birth weight and birth size. We determined the 
concentrations of TCS, TCC and metabolites as total concentrations in urine and cord blood plasma from a 
cohort of 181 expecting mothers in an urban, multiethnic population recruited between 2007-’09 in Brooklyn, NY. 
Maternal characteristics and birth outcomes were gathered from a technician-administered questionnaire and 
patient charts. We examined the relationship between concentrations of TCS, TCC and metabolites in maternal 
urine and cord blood plasma with gestational age, birth weight, and birth size. Correlations with birth outcomes 
yielded insights into the associations with exposure to TCS and TCC. This study is the first to report human 
biomonitoring data for TCC exposure in an urban population in the United States, and provides additional data 
on environmental exposure to TCS in the maternal-fetal unit. 
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